China Health Industries Holdings, Inc.
CHHE · OTC
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.50 | -0.13 | 3.91 | -0.04 |
| FCF Yield | 0.02% | -0.00% | -0.02% | -434.98% |
| EV / EBITDA | -340.18 | -103.66 | -2,297.02 | -8.01 |
| Quality | ||||
| ROIC | -4.53% | -13.25% | -0.42% | -1.38% |
| Gross Margin | -80,106.90% | -180,308.70% | -246.77% | -8.90% |
| Cash Conversion Ratio | -0.02 | 0.00 | 0.19 | 72.31 |
| Growth | ||||
| Revenue 3-Year CAGR | -39.46% | -54.08% | -67.34% | -74.19% |
| Free Cash Flow Growth | 1,079.18% | 99.02% | 99.92% | -190,803.10% |
| Safety | ||||
| Net Debt / EBITDA | -76.07 | -15.54 | -58.61 | -2.74 |
| Interest Coverage | -279.48 | -878.81 | -915.21 | -5,442.68 |
| Efficiency | ||||
| Inventory Turnover | 0.04 | 34.69 | 16.44 | 1.54 |
| Cash Conversion Cycle | -292,423.45 | 10,674.63 | -650.16 | -350.92 |